Skip to content
Directory

Treatment, Medication & Supplement Directory

A comprehensive encyclopedia of medicines, chemotherapy protocols, targeted and immune therapies, supplements, Chinese herbal formulas, Traditional Chinese Veterinary Medicine (TCVM) approaches, and supportive-care options used or discussed in canine and feline tumor care. Directory entries explain what each option is, where it may fit, its evidence and safety boundaries, and what to discuss with a veterinarian; they are references, not individualized prescriptions or rankings.

Directory explains “what it is.”Guides explain how owners can discuss, use, monitor, or prepare for a treatment option with veterinary guidance.
Filtered (2)
Filtered (2)
Filter

Filter

2 directory found

Type
See more See less
Species
See more See less
See more See less
See more See less
See more See less
See more See less
See more See less
See more See less
See more See less
See more See less
Product Family
See more See less
Regulatory Status
See more See less
Region / Availability
See more See less
Search
Apply(2) Reset
Show (2)
Cancel
Apply(2) Reset
2 entriesShowing 1–2
Calm dog receiving a monitored intravenous treatment in a veterinary clinicNamed profile Bleomycin in Veterinary Oncology: Local, Intracavitary and Pulmonary-Risk ProfileRepresentative category illustration – no product packaging is shown.
Chemotherapy · Prescription Drug · Single-agent Chemotherapy · Antineoplastic glycopeptide antibiotics · Dogs & Cats · During Chemotherapy · New Diagnosis

Bleomycin in Veterinary Oncology: Local, Intracavitary and Pulmonary-Risk Profile

bleomycin is covered as antineoplastic glycopeptide antibiotics; hazardous antineoplastic medicine, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.

Read more
Veterinarian demonstrating safe handling of an unbranded oral oncology medicine with a dog caregiverNamed profile Hydroxyurea in Veterinary Oncology: Myeloproliferative-Disease ProfileRepresentative category illustration – no product packaging is shown.
Chemotherapy · Prescription Drug · Single-agent Chemotherapy · Ribonucleotide-reductase inhibitors · Dogs & Cats · During Chemotherapy · New Diagnosis

Hydroxyurea in Veterinary Oncology: Myeloproliferative-Disease Profile

hydroxyurea is covered as ribonucleotide-reductase inhibitors; hazardous antineoplastic medicine, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.

Read more